Company / Net Income
Prime Medicine, Inc. Net Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$195.9M
FY2024
5-year range
-$198.1M / -$3.4M
FY2020-FY2024
Trend
+1.1%
vs FY2023
Sector context
#154 of 215
Health Care
What the data says
At -$196M, Prime Medicine, Inc.'s net income ranks #154 of 215 in the Health Care sector. Net Income has fluctuated over the past 5 years, ranging from -$198M in FY2023 to -$3M in FY2020.
Based on SEC 10-K filings.
-$196M in FY2024.
Declined from -$122M to -$196M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#154 of 215 in Health CareTop 72% of 215This company -$195.9M Sector average $431.3M
▼
-145.4% below sector average
Key checks
Key Insights
- In FY2024, net income increased 1.1% year-over-year.
- Ranks #154 out of 215 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
- Lowest net income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$195.9M | +1.1% |
| FY2023 | -$198.1M | -62.6% |
| FY2022 | -$121.8M | +26.3% |
| FY2021 | -$165.4M | -4749.5% |
| FY2020 | -$3.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026